EUVIMEDEUVIMED entdecken
Open Access

Plitidepsin as an Immunomodulator against Respiratory Viral Infections

Alejandro Losada, Nuria Izquierdo-Useros iD, Pablo Aviles iD, Júlia Vergara-Alert iD, Irene Latino iD, Joaquim Segalés iD, Santiago F Gonzalez iD, Carmen Cuevas, Dàlia Raïch-Regué iD, María J Muñoz-Alonso, Daniel Perez-Zsolt iD, Jordana Muñoz-Basagoiti und 12 weitere

The Journal of Immunology · 15.04.2024 · 212 (8) · 1307-1318

DOI: 10.4049/jimmunol.2300426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.02.2024. Verfasst von Alejandro Losada und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Development, PharmaMar S.A., Colmenar Viejo, Madrid, Spain. Hauptthemen laut MEDLINE: NF-kappa B, Influenza A Virus, H1N1 Subtype, Depsipeptides. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plitidepsin is a host-targeted compound known for inducing a strong anti–SARS-CoV-2 activity, as well as for having the capacity of reducing lung inflammation. Because IL-6 is one of the main cytokines involved in acute respiratory distress syndrome, the effect of plitidepsin in IL-6 secretion in different in vitro and in vivo experimental models was studied. A strong plitidepsin-mediated reduction of IL-6 was found in human monocyte-derived macrophages exposed to nonproductive SARS-CoV-2. In resiquimod (a ligand of TLR7/8)–stimulated THP1 human monocytes, plitidepsin-mediated reductions of IL-6 mRNA and IL-6 levels were also noticed. Additionally, although resiquimod-induced binding to DNA of NF-κB family members was unaffected by plitidepsin, a decrease in the regulated transcription by NF-κB (a key transcription factor involved in the inflammatory cascade) was observed. Furthermore, the phosphorylation of p65 that is required for full transcriptional NF-κB activity was significantly reduced by plitidepsin. Moreover, decreases of IL-6 levels and other proinflammatory cytokines were also seen in either SARS-CoV-2 or H1N1 influenza virus–infected mice, which were treated at low enough plitidepsin doses to not induce antiviral effects. In summary, plitidepsin is a promising therapeutic agent for the treatment of viral infections, not only because of its host-targeted antiviral effect, but also for its immunomodulatory effect, both of which were evidenced in vitro and in vivo by the decrease of proinflammatory cytokines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BInfluenza A Virus, H1N1 SubtypeDepsipeptidesHumansAnimalsMiceInterleukin-6Antiviral AgentsImmunologic FactorsCytokinesSARS-CoV-2

Substanzen

NF-kappa BplitidepsinInterleukin-6Antiviral AgentsImmunologic FactorsCytokinesDepsipeptides

Autor:innen und Institutionen

  • Department of Research and Development, PharmaMar S.A., Colmenar Viejo, Madrid, Spain.
  • IrsiCaixa AIDS Research Institute, Badalona, Spain.
  • Germans Trias i Pujol Research Institute, Can Ruti Campus, Badalona, Spain.
  • Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Unitat Mixta d'Investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal, Campus de la Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.
  • IRTA, Programa de Sanitat Animal, Centre de Recerca en Sanitat Animal, Campus de la Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.

ORCID-Profile: Nuria Izquierdo-Useros, Pablo Aviles, Júlia Vergara-Alert, Irene Latino, Joaquim Segalés, Santiago F Gonzalez, Dàlia Raïch-Regué, Daniel Perez-Zsolt, Jordi Rodon, Lauren A Chang, Marco Brustolin, Kris White, Michael Schotsaert, Adolfo García-Sastre

Förderung

  • NIDDK NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Losada, A., Izquierdo-Useros, N., Aviles, P., Vergara-Alert, J., Latino, I., Segalés, J., Gonzalez, S. F., Cuevas, C., Raïch-Regué, D., Muñoz-Alonso, M. J., Perez-Zsolt, D., Muñoz-Basagoiti, J., Rodon, J., Chang, L. A., Warang, P., Singh, G., Brustolin, M., Cantero, G., Roca, N., …, & García-Sastre, A. (2024). Plitidepsin as an Immunomodulator against Respiratory Viral Infections. The Journal of Immunology, 212(8), 1307-1318. https://doi.org/10.4049/jimmunol.2300426

Vancouver

Losada A, Izquierdo-Useros N, Aviles P, Vergara-Alert J, Latino I, Segalés J, et al. Plitidepsin as an Immunomodulator against Respiratory Viral Infections. The Journal of Immunology. 2024;212(8):1307-1318. doi:10.4049/jimmunol.2300426

BibTeX
@article{Losada2024,
  author = {Losada, Alejandro and Izquierdo-Useros, Nuria and Aviles, Pablo and Vergara-Alert, Júlia and Latino, Irene and Segalés, Joaquim and Gonzalez, Santiago F and Cuevas, Carmen and Raïch-Regué, Dàlia and Muñoz-Alonso, María J and Perez-Zsolt, Daniel and Muñoz-Basagoiti, Jordana and Rodon, Jordi and Chang, Lauren A and Warang, Prajakta and Singh, Gagandeep and Brustolin, Marco and Cantero, Guillermo and Roca, Núria and Pérez, Mònica and Bustos-Morán, Eugenio and White, Kris and Schotsaert, Michael and García-Sastre, Adolfo},
  title = {Plitidepsin as an Immunomodulator against Respiratory Viral Infections},
  journal = {The Journal of Immunology},
  year = {2024},
  volume = {212},
  number = {8},
  pages = {1307--1318},
  doi = {10.4049/jimmunol.2300426}
}
Kostenlos starten →